Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors.
Anzalone AV, Koblan LW, Liu DR. Nat Biotechnol. 2020 Jul;38(7):824-844. Pubmed
Therapeutic siRNA: state of the art
Hu B, Zhong L, Weng Y, Peng L, Huang Y, Zhao Y, Liang XJ. Signal Transduct Target Ther. 2020 Jun 19;5(1):101. Pubmed
Delivery of Oligonucleotides to the Liver with GalNAc: From Research to Registered Therapeutic Drug
Debacker AJ, Voutila J, Catley M, Blakey D, Habib N. Mol Ther. 2020 Jun 17:S1525-0016(20)30305-1. Pubmed
Phosphorothioate modified oligonucleotide-protein interactions
Crooke ST, Vickers TA, Liang XH. Nucleic Acids Res. 2020 Jun 4;48(10):5235-5253. Pubmed
Re-Evaluating the Conventional Wisdom about Binding Assays
Wilson BD, Soh HT. Trends Biochem Sci. 2020 May 10:S0968-0004(20)30108-0. Pubmed
Emerging siRNA Design Principles and Consequences for Biotransformation and Disposition in Drug Development
Humphreys SC, Thayer MB, Campbell J, Chen WLK, Adams D, Lade JM, Rock BM. J Med Chem. 2020 May 26. Pubmed
Technical Considerations for Use of Oligonucleotide Solution API
Muslehiddinoglu J, Simler R, Hill ML, Mueller C, Amery JHA, Dixon L, Watson A, Storch K, Gazziola C, Gielen F, Lange SA, Prail JD, Nesta DP. Nucleic Acid Ther. 2020 May 6. Pubmed
CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors
Wang D, Zhang F, Gao G. Cell. 2020 Apr 2;181(1):136-150. PubMed
Regulation of gene expression by cis-acting long non-coding RNAs
Gil N, Ulitsky I. Nat Rev Genet. 2020 Feb;21(2):102-117. PubMed
RNA Splicing by the Spliceosome.
Wilkinson ME, Charenton C, Nagai K. Annu Rev Biochem. 2019 Dec 3. PubMed